Skip to main content
Clinical Trials/NCT02292030
NCT02292030
Unknown
Not Applicable

Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure With or Without HTEA

Harbin Medical University2 sites in 1 country60 target enrollmentNovember 2014
InterventionsHTEA
DrugsHTEA

Overview

Phase
Not Applicable
Intervention
HTEA
Conditions
Chronic Heart Failure
Sponsor
Harbin Medical University
Enrollment
60
Locations
2
Primary Endpoint
recurrence of atrial fibrillation
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to explore the efficacy of low energy cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

Detailed Description

The purpose of this study is to explore the efficacy of low energy (30J) cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

Registry
clinicaltrials.gov
Start Date
November 2014
End Date
October 2015
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Harbin Medical University
Responsible Party
Principal Investigator
Principal Investigator

Wei Liu

Prof.

Harbin Medical University

Eligibility Criteria

Inclusion Criteria

  • congestive heart failure accompanied by atrial fibrillation.

Exclusion Criteria

  • Valvular heart diseases.

Arms & Interventions

cardioversion+HTEA

Heart failure patients accompanied by atrial fibrillation receive the treatment of cardioversion+HTEA.

Intervention: HTEA

only cardioversion

Heart failure patients accompanied by atrial fibrillation receive the treatment of cardioversion, but not with HTEA.

Intervention: HTEA

Outcomes

Primary Outcomes

recurrence of atrial fibrillation

Time Frame: 1 year

Study Sites (2)

Loading locations...

Similar Trials